Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"RNA, U6 small nuclear 46, pseudogene" (RNU6-46P) represents a **pseudogene** of the U6 small nuclear RNA family. U6 snRNA plays a key catalytic role in the spliceosome, the complex responsible for pre-mRNA splicing in eukaryotic cells[1][3]. The U6 family includes multiple genetic loci, many of which are pseudogenes in humans[2][3]. **Pseudogenes** are non-functional copies of genes that generally do not produce active RNA or protein. Unlike functional U6 snRNA genes, RNU6-46P is not involved in splicing or other biological processes and is not considered a drug target, biomarker, or safety liability. Pseudogenes such as this may serve as evolutionary markers and can be involved in retrotransposition events, but they lack therapeutic relevance and do not possess known physiological or pathological functions[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U6 small nuclear RNA 46, pseudogene (RNU6-46P).